Crinetics Pharmaceuticals
CRNX
CRNX
50 hedge funds and large institutions have $503M invested in Crinetics Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
2.53% more ownership
Funds ownership: 67.3% → 69.83% (+2.5%)
2% more funds holding
Funds holding: 49 → 50 (+1)
Holders
50
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$8.21M | |
| 2 | +$6.62M | |
| 3 | +$5.22M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.7M |
| 5 |
EU
Emory University
Atlanta,
Georgia
|
+$2.58M |
Top Sellers
| 1 | -$3.37M | |
| 2 | -$1.42M | |
| 3 | -$1.39M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$1.22M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$895K |